GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
Novavax Begins Phase 2 For COVID-19/Influenza Combination And Stand-Alone Flu Shots
2023-01-03
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
TG Notches FDA Victory For CD20 Antibody For Multiple Sclerosis
2022-12-29
Acer Snags First-Ever FDA Approval With Relief-Partnered Olpruva
2022-12-28
Immutep Expands Patient Population For LAG-3 Candidate After FDA Meeting
2022-12-26
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
1 2 3 4 5 46
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top